Are Options Traders Betting on a Big Move in Regeneron Stock?

Zacks · 2026-06-02T13:25:00Z

3 Nasdaq 100 Stocks We Find Risky

StockStory · 2026-06-01T21:20:51Z

Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound? (Revised)

Zacks · 2026-06-01T14:35:00Z

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength (Revised)

Zacks · 2026-06-01T14:34:00Z

Is Regeneron Pharmaceuticals Stock Underperforming the Dow?

Barchart · 2026-06-01T10:42:21Z

Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application

Insider Monkey · 2026-05-31T08:23:59Z

Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound?

Zacks · 2026-05-29T15:30:21Z

Regeneron And Parabilis Target Undruggable Proteins As Valuation Draws Interest

Simply Wall St. · 2026-05-28T15:04:03Z

These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth

24/7 Wall St. · 2026-05-28T15:04:00Z

Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results

Investor's Business Daily · 2026-05-27T20:05:25Z